Comprehensive 18F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 50,333 followers.

Comprehensive 18F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study https://t.co/qKsBq0Cu43 https://t.co/mYgSLPQUGe

19 Nov 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Comprehensive 18F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemo…

17 Nov 2022

Reply Repost Favourite

New Research: Comprehensive 18F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study: Purpose To develop a comprehensive PET… https://t.co/8LlkC

17 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.